月度归档： 2026 年 6 月

By Mike May, PhD Credit: Image generated with Google GeminiHuman pluripotent stem cells (hPSCs) have long been viewed as one of regenerative medicine’s most promising raw materials. Now, as more than 100 clinical trials evaluate hPSC-derived therapies for diseases ranging from Parkinson’s disease to heart failure and type 1 diabetes, attention is turning toward a crucial challenge: how to manufacture these cells reliably and economically at industrial scale.

As AI infrastructure for drug discovery continues to proliferate with reasoning workflows capable of generating hypotheses, candidate molecules, and experimental plans, Medra CEO Michelle Lee, PhD, argues that physical AI is the solution to addressing the next bottleneck: experimental validation at scale.  

SAN DIEGO—California’s three life sciences clusters all lost jobs last year, yet the industry remains a major engine of innovation and economic growth, according to a report released by the state’s largest life sciences organization to coincide with the Biotechnology Industry Organization (BIO) International Convention being held here.

Credit: NvidiaNvidia has announced the NVIDIA BioNeMo Agent Toolkit, which turns complex scientific workflows into agent-executable tasks, including model selection, input preparation, workflow execution, output inspection, and results explanation.

Congress members from across the aisle are taking aim at a sustainable alternative to butter by painting it as a “billionaire food experiment” that is “riding [the] coattails” of dairy farmers.

UK gut health supplement brand Myota has closed a $4.5M Series A investment round to expand the reach of its prebiotic fibre supplements for consumers and the food industry.